NSN 6505-01-528-6349
Part Details | USP CEFTAZIDIME FOR INJECTION
6505-01-528-6349
Alternate Parts: 050144, 05-0144, NDC00409509311, NDC00409-5093-11, 6505-01-528-6349, 01-528-6349, 6505015286349, 015286349
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 21, 2005 | 01-528-6349 | 42844 ( CEFTAZIDIME FOR INJECTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-528-6349
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 05-0144 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC00409-5093-11 | 3VBU6 | HOSPIRA, INC. |
Technical Data | NSN 6505-01-528-6349
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BZ2.000 GRAMS CEFTAZIDIME, ANHYDROUS |
| PHYSICAL FORM | POWDER |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 18.000 MILLILITERS AFTER RECONSTITUTION |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| FEATURES PROVIDED | STERILE |
| SPECIAL FEATURES | STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; FOR IV USE; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 10S |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 081206 |
| SUPPLEMENTARY FEATURES | ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME F/INJ 2GM ADD-VANTAGE VIAL, 10'S |
